Breast Inflammatory Carcinoma — Trials

Breast Inflammatory Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

56 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 4
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: M.D. Anderson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (12)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05177796	Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer	withdrawn	Phase 2	0	M.D. Anderson Cancer CenterOTHER	1	Oct 24, 2024	clinicaltrials
NCT06057636	Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study	withdrawn	N/A	0	The University of Tennessee, KnoxvilleOTHER	1	May 10, 2024	clinicaltrials